Literature DB >> 12563321

Cyclin E is a more powerful predictor of breast cancer outcome than proliferation.

Khandan Keyomarsi, Susan L Tucker, Isabelle Bedrosian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12563321     DOI： 10.1038/nm0203-152

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Hypoxia-inducible factor 1 is activated by dysregulated cyclin E during mammary epithelial morphogenesis.

Authors:  Tanushri Sengupta; Gathi Abraham; Yanfei Xu; Bruce E Clurman; Alex C Minella
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

2.  LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.

Authors:  Qingsong Hu; Chunlai Li; Shouyu Wang; Yajuan Li; Bo Wen; Yanyan Zhang; Ke Liang; Jun Yao; Youqiong Ye; Heidi Hsiao; Tina K Nguyen; Peter K Park; Sergey D Egranov; David H Hawke; Jeffrey R Marks; Leng Han; Mien-Chie Hung; Bing Zhang; Chunru Lin; Liuqing Yang
Journal:  Cell Res       Date:  2019-01-10       Impact factor: 25.617

3.  CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.

Authors:  Ayse Ayhan; Elisabetta Kuhn; Ren-Chin Wu; Hiroshi Ogawa; Asli Bahadirli-Talbott; Tsui-Lien Mao; Haruhiko Sugimura; Ie-Ming Shih; Tian-Li Wang
Journal:  Mod Pathol       Date:  2016-10-21       Impact factor: 7.842

4.  Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.

Authors:  Xinyu Zheng; Xiao-Mei Rao; Jorge G Gomez-Gutierrez; Hongying Hao; Kelly M McMasters; H Sam Zhou
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

5.  A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels.

Authors:  Christine M Stellrecht; Mary Ayres; Rishi Arya; Varsha Gandhi
Journal:  Breast Cancer Res Treat       Date:  2009-07-30       Impact factor: 4.872

6.  Cyclin E is stabilized in response to replication fork barriers leading to prolonged S phase arrest.

Authors:  Xiaoyan Lu; Jia Liu; Randy J Legerski
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

7.  Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

Authors:  Anders Ström; Johan Hartman; James S Foster; Silke Kietz; Jay Wimalasena; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

8.  Brk is coamplified with ErbB2 to promote proliferation in breast cancer.

Authors:  Bin Xiang; Kiranam Chatti; Haoqun Qiu; B Lakshmi; Alexander Krasnitz; Jim Hicks; Min Yu; W Todd Miller; Senthil K Muthuswamy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

9.  CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma.

Authors:  Naoki Kawahara; Yuki Yamada; Hiroshi Kobayashi
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

10.  The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility.

Authors:  Ruwin Pandithage; Richard Lilischkis; Kai Harting; Alexandra Wolf; Britta Jedamzik; Juliane Lüscher-Firzlaff; Jörg Vervoorts; Edwin Lasonder; Elisabeth Kremmer; Bernd Knöll; Bernhard Lüscher
Journal:  J Cell Biol       Date:  2008-03-10       Impact factor: 10.539
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.